Home/Filings/4/0001225208-24-005927
4//SEC Filing

Tsourapas Panagiotis 4

Accession 0001225208-24-005927

CIK 0000021665other

Filed

May 9, 8:00 PM ET

Accepted

May 10, 4:16 PM ET

Size

10.4 KB

Accession

0001225208-24-005927

Insider Transaction Report

Form 4
Period: 2024-05-09
Tsourapas Panagiotis
Pres., Colgate-Africa/Eurasia
Transactions
  • Exercise/Conversion

    Common Stock

    2024-05-09$72.29/sh+12,000$867,48017,118 total
  • Sale

    Common Stock

    2024-05-09$94.15/sh12,000$1,129,8545,118 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-05-0912,00054,794 total
    Exercise: $72.29Exp: 2027-09-12Common Stock (12,000 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    69,204
  • Common Stock

    (indirect: By Trust)
    4,345
Footnotes (5)
  • [F1]Exercise of stock options awarded under the issuer's incentive compensation plan.
  • [F2]Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding.
  • [F3]Weighted average price, as these shares were sold in multiple transactions at prices ranging from $94.15 to $94.1703, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]This amount includes 9,922 shares that were previously reported as directly beneficially owned.
  • [F5]Option became exercisable in one-third increments beginning on the first anniversary of the September 12, 2019 grant date.

Documents

1 file

Issuer

COLGATE PALMOLIVE CO

CIK 0000021665

Entity typeother

Related Parties

1
  • filerCIK 0001576945

Filing Metadata

Form type
4
Filed
May 9, 8:00 PM ET
Accepted
May 10, 4:16 PM ET
Size
10.4 KB